• Home
  • Latest
  • Coins2Day 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 57 of 100
World Science Festival
HealthWhat You Should Know About ALS, The Disease That Killed Actor and Playwright Sam Shepard
By Sy MukherjeeJuly 31, 2017
Former Turing Pharmaceuticals CEO Martin Shkreli Case Nears End As Lawyers Prepare For Final Argument
FinanceJury to Soon Begin Deliberations in ‘Pharma Bro’ Martin Shkreli’s Fraud Trial
By ReutersJuly 28, 2017
A sign is seen at an AstraZeneca site in Macclesfield
HealthHere’s Why Shares in This Former Pfizer Target Are Tanking
By Coins2Day Editors and ReutersJuly 27, 2017
Close up of blister packs red pills
EyebrowMitsubishi Tanabe Pharma Is Buying Neuroderm in a $1.1 Billion Bid to Expand Its U.S. Business
By ReutersJuly 24, 2017
Cystic fibrosis drug campaign
HealthThis Biotech Just Gained Billions in Market Value Thanks to Its Cystic Fibrosis Drug Cocktail
By Sy MukherjeeJuly 19, 2017
HealthFDA Panel Backs Groundbreaking Novartis Treatment That Turns Your Cells Into Cancer Killers
By Sy MukherjeeJuly 12, 2017
Sickle Cell Anemia SEM
HealthThe FDA Approved the First New Sickle Cell Drug in 20 Years…But It’s Not a Cure
By Sy MukherjeeJuly 10, 2017
Neisseria Gonorrhoeae
Health‘Smart’ Gonorrhea Is the Latest Threat In a Troubling Superbug Trend
By Sy MukherjeeJuly 8, 2017
View of stethoscope on table in laboratory
HealthDrug and Device Makers Shelled Out $8 Billion to Doctors and Hospitals Last Year
By Sy MukherjeeJuly 6, 2017
White tablets
CommentaryHow Expanding Generic Drugs Can Add to America’s Health Care Woes
By Tim Calkins and Bethany CiancioloJuly 6, 2017
Former Turing Pharmaceuticals CEO Martin Shkreli On Trial For Securities Fraud
FinanceInvestor In Martin Shkreli’s Fund Says He Made Millions Despite Being Lied To
By ReutersJuly 6, 2017
HealthTwo Stories That Help Explain Runaway Drug Prices
By Clifton LeafJune 30, 2017
Stefano Pessina, Executive Deputy Chairm
RetailWalgreens Scraps Rite Aid Deal and Will Instead Buy 2,200 Stores for $5 Billion
By Phil WahbaJune 29, 2017
House Oversight Hearing On Prescription Drug Price Increases
Finance‘Pharma Bro’ Martin Shkreli Begins His Fraud Trial Monday
By ReutersJune 26, 2017
Mylan NV EpiPen 2-Pak medication sits on a table inside a pharmacy in Provo, Utah, U.S., on Wednesday, Aug. 31, 2016.
HealthWill the Newest EpiPen Competitor Steal Even More Market Share from Mylan?
By Sy MukherjeeJune 19, 2017
1...
  • 55
  • 56
  • 57
  • 58
  • 59
...100
Most Popular
Success
In 2026, many employers are ditching merit-based pay bumps in favor of ‘peanut butter raises’An image of a popular article
By Emma BurleighFebruary 2, 2026
Cybersecurity
Top AI leaders are begging people not to use Moltbook, a social media platform for AI agents: It’s a ‘disaster waiting to happen’An image of a popular article
By Eva RoytburgFebruary 2, 2026
Economy
Trump may have shot himself in the foot at the Fed, as Powell could stay on while Miran resigns from White House postAn image of a popular article
By Eleanor PringleFebruary 4, 2026
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.